Skip to main content

Effects of the Impairment of Renal Function and of the pH of Gastric Secretion on the Efficacy of Al(OH)3 to Reduce Serum Inorganic Phosphorus

  • Chapter
Phosphate and Mineral Homeostasis

Abstract

In spite of the demonstration that the Al of the antacids is absorbed in the gastrointestinal tract (1, 2, 3, 4) and that its retention may cause severe adverse effects in patients with chronic renal failure (CRF) (5, 6, 7, 8), the Al-containing phosphate binders continue to be widely used to correct hyperphosphatemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. G.M.Berlyne, D. Pezt, J. Ben-Ari, J.Weinberger, M.Stein, G.R.Gilmore, R.Levine, Hyperaluminemia from aluminium resins in renal failure, Lancet ií: 494 (1970).

    Google Scholar 

  2. W.D.Kaenny, A.P. Hegg, A.C.Alfrey, Gastrointestinal absorption of aluminium from aluminium containing antacids, New Engl.J.Med.296: 1389 (1977).

    Article  Google Scholar 

  3. A.D. Cumming, J.F. Cowie, R.J. Winney, Factors influencing the plasma Aluminium concentration in hemodialysed patients, Dialysis and Transpl. 13: 692 (1984).

    Google Scholar 

  4. O.Knoll, H.Kellinghans, M.P.Bertam, H. Zumkley, U.Graefe, Gastrointestinal absorption of aluminium in chronic renal insufficiency, Contr. Nephrol. 38: 24 (1984).

    Google Scholar 

  5. F.P.Masselot, J.P. Adhemar, M.C. Jaudon,D.Kleinknecht, A.Galli, Reversible dialysis encephalopathy:role of aluminium containing gels, Lancet ii: 1386 (1978).

    Article  Google Scholar 

  6. M.Poisson, R. Mashaly, B. Lebkiri, Dialysis encepalopathy:recovery after interruption of aluminium intake, Brit.Med. J. 2: 1610 (1978).

    Article  Google Scholar 

  7. S.P.Andreoli, J.M. Bergstein, D.J.Sherrard, Aluminium intoxication from aluminium-containing phosphate binders in children with azotemia not undergoing dialysis, New Engl.J.Med. 310, 1079 (1984).

    Google Scholar 

  8. G. Cournot-Witmer, Aluminium osteodystrophy, Contr.Nephrol. 38: 59 (1984).

    Google Scholar 

  9. D.B.Ziversmith, A.K.Davis, Microdetermination of plasma phospholipids by trichloroacetic acid precipitation, J.Lab.Clin.Med. 35: 155 (1950).

    Google Scholar 

  10. G.Barsotti, M.Lazzeri, A.Polloni, A.Giannoni, C.Cristofano,E.Morelli,Hypochloridria and serum gastrin levels in chronic renal failure, in: "Abstract Book - Int. Congress of Nephrology" pag.341 A, Los Angeles 1984.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Press, New York

About this chapter

Cite this chapter

Barsotti, G. et al. (1986). Effects of the Impairment of Renal Function and of the pH of Gastric Secretion on the Efficacy of Al(OH)3 to Reduce Serum Inorganic Phosphorus. In: Massry, S.G., Olmer, M., Ritz, E. (eds) Phosphate and Mineral Homeostasis. Advances in Experimental Medicine and Biology, vol 208. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5206-8_61

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5206-8_61

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5208-2

  • Online ISBN: 978-1-4684-5206-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics